Glenmark planning to submit new drug application
Glenmark Pharmaceuticals said on Monday it is planning to submit new drug application in the US for Crofelemer used in the treatment of HIV-associated diarrhoea.
Drug firm Glenmark today said it has opened its new facility in Argentina which would serve as a global hub for cancer treatment drugs.